Selected research
Industry Research
Cyclosporine Industry Research Report 2026
Market perspective
The global Cyclosporine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cyclosporine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cyclosporine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cyclosporine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cyclosporine include Alcon, Allergan, Herantis Pharma, Mimetogen Pharmaceuticals, Mitotech, Otsuka Pharmaceutical, Regenerx Biopharmaceuticals, Santen Pharmaceutical and United Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cyclosporine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cyclosporine Market by Company
Alcon
Allergan
Herantis Pharma
Mimetogen Pharmaceuticals
Mitotech
Otsuka Pharmaceutical
Regenerx Biopharmaceuticals
Santen Pharmaceutical
United Biotech
Takeda
Cyclosporine Segment by Type
Pills
Oral
Cyclosporine Segment by Application
Hospital
Clinic
Others
Cyclosporine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclosporine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclosporine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclosporine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cyclosporine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cyclosporine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cyclosporine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pills
- Oral
Applications
- Hospital
- Clinic
- Others
Companies covered
- Alcon
- Allergan
- Herantis Pharma
- Mimetogen Pharmaceuticals
- Mitotech
- Otsuka Pharmaceutical
- Regenerx Biopharmaceuticals
- Santen Pharmaceutical
- United Biotech
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cyclosporine Market Size (2021-2032)
- 2.2.2 Global Cyclosporine Sales (2021-2032)
- 2.2.3 Global Cyclosporine Market Average Price (2021-2032)
- 2.3 Cyclosporine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pills
- 2.3.3 Oral
- 2.4 Cyclosporine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cyclosporine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cyclosporine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cyclosporine Revenue of Manufacturers (2021-2026)
- 3.4 Global Cyclosporine Average Price by Manufacturers (2021-2026)
- 3.5 Global Cyclosporine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cyclosporine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cyclosporine, Product Type & Application
- 3.8 Global Manufacturers of Cyclosporine, Established Date
- 3.9 Global Cyclosporine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alcon
- 4.1.1 Alcon Company Information
- 4.1.2 Alcon Business Overview
- 4.1.3 Alcon Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alcon Cyclosporine Product Portfolio
- 4.1.5 Alcon Recent Developments
- 4.2 Allergan
- 4.2.1 Allergan Company Information
- 4.2.2 Allergan Business Overview
- 4.2.3 Allergan Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Allergan Cyclosporine Product Portfolio
- 4.2.5 Allergan Recent Developments
- 4.3 Herantis Pharma
- 4.3.1 Herantis Pharma Company Information
- 4.3.2 Herantis Pharma Business Overview
- 4.3.3 Herantis Pharma Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Herantis Pharma Cyclosporine Product Portfolio
- 4.3.5 Herantis Pharma Recent Developments
- 4.4 Mimetogen Pharmaceuticals
- 4.4.1 Mimetogen Pharmaceuticals Company Information
- 4.4.2 Mimetogen Pharmaceuticals Business Overview
- 4.4.3 Mimetogen Pharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mimetogen Pharmaceuticals Cyclosporine Product Portfolio
- 4.4.5 Mimetogen Pharmaceuticals Recent Developments
- 4.5 Mitotech
- 4.5.1 Mitotech Company Information
- 4.5.2 Mitotech Business Overview
- 4.5.3 Mitotech Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mitotech Cyclosporine Product Portfolio
- 4.5.5 Mitotech Recent Developments
- 4.6 Otsuka Pharmaceutical
- 4.6.1 Otsuka Pharmaceutical Company Information
- 4.6.2 Otsuka Pharmaceutical Business Overview
- 4.6.3 Otsuka Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Otsuka Pharmaceutical Cyclosporine Product Portfolio
- 4.6.5 Otsuka Pharmaceutical Recent Developments
- 4.7 Regenerx Biopharmaceuticals
- 4.7.1 Regenerx Biopharmaceuticals Company Information
- 4.7.2 Regenerx Biopharmaceuticals Business Overview
- 4.7.3 Regenerx Biopharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Regenerx Biopharmaceuticals Cyclosporine Product Portfolio
- 4.7.5 Regenerx Biopharmaceuticals Recent Developments
- 4.8 Santen Pharmaceutical
- 4.8.1 Santen Pharmaceutical Company Information
- 4.8.2 Santen Pharmaceutical Business Overview
- 4.8.3 Santen Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Santen Pharmaceutical Cyclosporine Product Portfolio
- 4.8.5 Santen Pharmaceutical Recent Developments
- 4.9 United Biotech
- 4.9.1 United Biotech Company Information
- 4.9.2 United Biotech Business Overview
- 4.9.3 United Biotech Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 United Biotech Cyclosporine Product Portfolio
- 4.9.5 United Biotech Recent Developments
- 4.10 Takeda
- 4.10.1 Takeda Company Information
- 4.10.2 Takeda Business Overview
- 4.10.3 Takeda Cyclosporine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Takeda Cyclosporine Product Portfolio
- 4.10.5 Takeda Recent Developments
5 Global Cyclosporine Market Scenario by Region
- 5.1 Global Cyclosporine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cyclosporine Sales by Region: 2021-2032
- 5.2.1 Global Cyclosporine Sales by Region: 2021-2026
- 5.2.2 Global Cyclosporine Sales by Region: 2027-2032
- 5.3 Global Cyclosporine Revenue by Region: 2021-2032
- 5.3.1 Global Cyclosporine Revenue by Region: 2021-2026
- 5.3.2 Global Cyclosporine Revenue by Region: 2027-2032
- 5.4 North America Cyclosporine Market Facts & Figures by Country
- 5.4.1 North America Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cyclosporine Sales by Country (2021-2032)
- 5.4.3 North America Cyclosporine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cyclosporine Market Facts & Figures by Country
- 5.5.1 Europe Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cyclosporine Sales by Country (2021-2032)
- 5.5.3 Europe Cyclosporine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cyclosporine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cyclosporine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cyclosporine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cyclosporine Market Facts & Figures by Country
- 5.7.1 South America Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cyclosporine Sales by Country (2021-2032)
- 5.7.3 South America Cyclosporine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Cyclosporine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cyclosporine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cyclosporine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cyclosporine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cyclosporine Sales by Type (2021-2032)
- 6.1.1 Global Cyclosporine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cyclosporine Sales Market Share by Type (2021-2032)
- 6.2 Global Cyclosporine Revenue by Type (2021-2032)
- 6.2.1 Global Cyclosporine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cyclosporine Revenue Market Share by Type (2021-2032)
- 6.3 Global Cyclosporine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cyclosporine Sales by Application (2021-2032)
- 7.1.1 Global Cyclosporine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cyclosporine Sales Market Share by Application (2021-2032)
- 7.2 Global Cyclosporine Revenue by Application (2021-2032)
- 7.2.1 Global Cyclosporine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cyclosporine Revenue Market Share by Application (2021-2032)
- 7.3 Global Cyclosporine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cyclosporine Value Chain Analysis
- 8.1.1 Cyclosporine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cyclosporine Production Mode & Process
- 8.2 Cyclosporine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cyclosporine Distributors
- 8.2.3 Cyclosporine Customers
9 Global Cyclosporine Analyzing Market Dynamics
- 9.1 Cyclosporine Industry Trends
- 9.2 Cyclosporine Industry Drivers
- 9.3 Cyclosporine Industry Opportunities and Challenges
- 9.4 Cyclosporine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst